News
Pfizer's (NYSE:PFE) stock up by 7.7% over the past three months. However, we decided to study the company's mixed-bag of ...
In the recent 13F filings, Pfizer has seen a mix of investment adjustments from 11 institutions, reflecting a divided market ...
Oppenheimer initiated coverage of the buy now, pay later firm Monday, issuing an "outperform" rating for Affirm stock.
While its shares have been lagging the market significantly, that could change in the next decade as financial results ...
PepsiCo shares could remain on watchlists after surging last week following a better-than-expected earnings report and outlook from the beverage and snack food giant. Monitor these key post-earnings ...
Pfizer recently recalibrated its evaluation score, a nod to shifting trends in the market and its own financial pulse. The ...
Gold Spot US Dollar, Intel Corporation, Microsoft Corporation, Cisco Systems Inc. Read 's Market Analysis on Investing.com UK.
It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth ...
While Pfizer's dividend yield is clearly much higher than Merck's, both have relatively attractive yields today. And you ...
Pfizer Inc. (NYSE:PFE) hasn’t performed well in recent years, with its stock declining more than 26% over the past decade.
A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that deuruxolitinib (Leqselvi; Sun Pharma) at a dosage of 12 mg twice daily for 24 ...
Pfizer Inc. (NYSE:PFE) is one of the best cheap stocks under $50 to buy now. On July 10, Morgan Stanley analyst Terrence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results